Bioventus (BVS) EBIT Growth (1y) (2021 - 2026)
Bioventus (BVS) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 16.18% |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn | 4.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 4.13% |
| Mar 28, 2026 | 72.85% |
| Dec 31, 2025 | 152.97% |
| Sep 27, 2025 | 208.53% |
| Jun 28, 2025 | 158.36% |
| Mar 29, 2025 | -1.20% |
| Dec 31, 2024 | 561.20% |
| Sep 28, 2024 | 50.83% |
| Jun 29, 2024 | -566.27% |
| Mar 30, 2024 | 105.35% |
| Dec 31, 2023 | 107.45% |
| Sep 30, 2023 | 101.91% |
| Jul 1, 2023 | 304.05% |
| Apr 1, 2023 | -329.17% |
| Dec 31, 2022 | -396.41% |
| Oct 1, 2022 | -12,014.52% |
| Jul 2, 2022 | 42.37% |
| Apr 2, 2022 | -197.51% |
| Dec 31, 2021 | -153.32% |
| Oct 2, 2021 | -115.10% |